<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02108756</url>
  </required_header>
  <id_info>
    <org_study_id>2014-CTTQ-SPAN</org_study_id>
    <nct_id>NCT02108756</nct_id>
  </id_info>
  <brief_title>Efficacy and Safety of L-Pantoprazole Sodium Injection to Treat Upper Gastrointestinal Ulcer Bleeding</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the safety and Efficacy of L- Pantoprazole sodium to
      treat upper gastrointestinal ulcer bleeding.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>February 2014</start_date>
  <completion_date type="Anticipated">June 2015</completion_date>
  <primary_completion_date type="Anticipated">April 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Hemostatic success rate</measure>
    <time_frame>6 days</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">272</enrollment>
  <condition>Bleeding Gastric Ulcer</condition>
  <condition>Bleeding Duodenal Ulcer</condition>
  <arm_group>
    <arm_group_label>L-pantoprazole sodium</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Panmeilu</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>L-pantoprazole sodium</intervention_name>
    <description>2 injection L-pantoprazole sodium (40mg), Bid</description>
    <arm_group_label>L-pantoprazole sodium</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Panmeilu</intervention_name>
    <description>An injection Panmeilu (80 mg) + 1 branch placebo, Bid;</description>
    <arm_group_label>Panmeilu</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Age: 18-65 years, gender:both.

          2. Patients whose Forrest classification were in Ⅰ b-Ⅱ c were diagnosed with non-variceal
             duodenal and / or gastric ulcer bleeding by endoscopy within 24 hours and patients
             manifested vomiting and / or black stools and other symptoms of upper gastrointestinal
             bleeding.

          3. Patients were diagnosed with upper gastrointestinal bleeding mild to moderate;

          4. Informed consent granted.

          5. Patients agreed to take medicine and assess.

        Exclusion Criteria:

          1. Patients were diagnosed with upper gastrointestinal bleeding by endoscopy caused by
             esophageal varices and portal hypertensive gastropathy, Mallory-Weiss syndrome,
             dieulafoy disease.

          2. Pregnant women or breastfeeding women.

          3. Patients who had undergone surgery because of ulcer complications or gastrectomy,
             gastrointestinal anastomosis within 30 days before the trial.

          4. Patients were diagnosed with gastrinoma or gastric malignancy.

          5. Patients had other associated complications, which may affect the efficacy.

          6. Patients who like alcohol abuse, drug addicts or others which are not suitable for
             drug trials.

          7. Patients who were allergic to any ingredient of any PPI and allergies.

          8. Patients diagnosed with small vessel spurting who had to undergo endoscopic hemostasis
             or surgery or severe gastrointestinal bleeding.

          9. Patients suffering from serious heart, brain, lung, liver, kidney disease or severe
             hypertension.

         10. Patients who had coagulopathy, whose PT wasmore three seconds than normal controls,
             whose APTT&gt; 1.5 times the upper limit of normal or low-dose heparin treatment.

         11. Patients whose systolic blood pressure less than 90mmHg or lower &gt; 30mmHg than the
             baseline systolic blood pressure, pulse pressure less than 20mmHg, hematocrit less
             than 20%.

         12. Patients who participated in other clinical trials within three months before this
             trial.

         13. Patients who need to use other drugs which may affect the trial during the trial or a
             week before the trial.

         14. Patients who were considered unsuitable for selected candidates.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Han Ying, doctor</last_name>
    <phone>13991963770</phone>
    <email>hanying@fmmu.edu.cn</email>
  </overall_contact>
  <location>
    <facility>
      <name>The first affiliated hospital of the Fourth Military Medical University</name>
      <address>
        <city>Xi'an</city>
        <state>Shaanxi</state>
        <zip>710032</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Han Ying, doctor</last_name>
      <phone>13991963770</phone>
      <email>hanying@fmmu.edu.cn</email>
    </contact>
    <investigator>
      <last_name>Fan Dai ming, doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Wu Kai chun, doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Han Ying, doctor</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>April 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 7, 2014</study_first_submitted>
  <study_first_submitted_qc>April 8, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 9, 2014</study_first_posted>
  <last_update_submitted>April 8, 2014</last_update_submitted>
  <last_update_submitted_qc>April 8, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 9, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ulcer</mesh_term>
    <mesh_term>Hemorrhage</mesh_term>
    <mesh_term>Stomach Ulcer</mesh_term>
    <mesh_term>Duodenal Ulcer</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pantoprazole</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

